Nuwellis, Inc.
NCM: NUWELive Quote
📈 ZcoreAI Score
Our AI model analyzes Nuwellis, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get NUWE Z-Score →About Nuwellis, Inc.
Healthcare
Medical Devices
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through specialty healthcare distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
📊 Fundamental Analysis
Nuwellis, Inc. demonstrates a profit margin of -211.9%, which is below the sector average, suggesting competitive pressure.
The company recently reported 4.4% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is -382.6%, which indicates that capital utilization is currently under pressure.
At a current price of $1.08, NUWE currently trades near the bottom of its 52-week range (0%), indicating potential value or weakness (Range: $0.96 - $45.36).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$2.86M
Trailing P/E
--
Forward P/E
-0.42
Beta (5Y)
0.08
52W High
$45.36
52W Low
$0.96
Avg Volume
2.19M
Day High
Day Low